Crinetics Pharmaceuticals Inc (CRNX)

Cash & Equivalents

$55.50M

Quarterly · Period ending: · USD

CRNX logo

CRNX Cash & Equivalents

Latest reported$101.54M
CRNX FY Cash & Equivalents ($12.15M → $101.54M)
High-resolution chart · PNG

CRNX cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
101,536,000
264,545,000
54,897,000
32,671,999
200,695,000
93,087,000
40,326,000
44,973,000
14,192,000
12,152,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.